86 results
8-K
EX-99.1
CLSD
Clearside Biomedical Inc
12 Mar 24
Results of Operations and Financial Condition
4:16pm
, we are looking to replicate the excellent safety profile, stable vision, and reduced frequency of injections over 6 months that we observed in our … OASIS Phase 1/2a and Extension Study.”
“In addition, our development and commercialization partners continue to report positive safety and efficacy
8-K
EX-10.1
CLSD
Clearside Biomedical Inc
8 Feb 24
Clearside Biomedical Announces Pricing of $15 Million Registered
5:05pm
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case
8-K
EX-99.1
r1tuf7r7ivc0dmvol
13 Nov 23
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
4:10pm
8-K
kx02k7lww6 83
3 Nov 23
Entry into a Material Definitive Agreement
12:01pm
8-K
EX-99.1
mpqresh1w4nu
14 Aug 23
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
ytk fnwqmmqxpd5a8fk4
11 May 23
Results of Operations and Financial Condition
7:15am
8-K
EX-99.2
e1g6pfe mon89nxzbb7
9 Nov 22
Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
8:29am
8-K
EX-99.3
aptsf ndju
9 Nov 22
Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
8:29am
8-K
EX-99.1
e30kp08
9 Nov 22
Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
8:29am
8-K
jnaaonw uxnu
9 Nov 22
Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
8:29am
8-K
EX-99.1
n7i3qriba19wn6om
9 Aug 22
Clearside Biomedical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
7:17am